Noninvasive detection of myocardial fibrosis in Arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging

Division of Cardiology, The Johns Hopkins University, Baltimore, MD 21287, USA.
Journal of the American College of Cardiology (Impact Factor: 15.34). 02/2005; 45(1):98-103. DOI: 10.1016/j.jacc.2004.09.053
Source: PubMed

ABSTRACT We evaluated the role of myocardial delayed-enhancement (MDE) magnetic resonance imaging (MRI) for noninvasive detection of fibrosis in Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C).
Arrhythmogenic right ventricular dysplasia/cardiomyopathy is characterized by fibro-fatty replacement of the right ventricle (RV) leading to arrhythmias and RV failure. Endomyocardial biopsy can demonstrate fibro-fatty replacement of the RV myocardium; however, the test is invasive and carries a risk of perforation.
Thirty consecutive patients were prospectively evaluated for ARVD/C. Magnetic resonance imaging was performed on a 1.5-T scanner. Ten minutes after intravenous administration of 0.2 mmol/kg of gadodiamide, MDE-MRI was obtained. Diagnosis of ARVD/C was based upon the Task Force criteria and did not include MRI findings.
Twelve (40%) of 30 patients met the Task Force criteria for ARVD/C. Eight (67%) of the 12 ARVD/C patients demonstrated increased signal on MDE-MRI in the RV compared with none (0%) of the 18 patients without ARVD/C (p <0.001). Endomyocardial biopsy was performed in 9 of the 12 ARVD/C patients. Of the nine patients, four had fibro-fatty changes consistent with the diagnosis of ARVD/C. Each of these patients had increased RV signal on MDE-MRI. None of the patients without ARVD/C had any abnormalities either on histopathology or on MDE-MRI. Electrophysiologic testing revealed inducible sustained ventricular tachycardia (VT) in six of the eight ARVD/C patients with delayed enhancement, compared with none of the ARVD/C patients without delayed enhancement (p=0.01).
Noninvasive detection of RV myocardial fibro-fatty changes in ARVD/C is possible by MDE-MRI. Magnetic resonance imaging findings had an excellent correlation with histopathology and predicted inducible VT on programmed electrical stimulation, suggesting a possible role in evaluation and diagnosis of patients with suspected ARVD/C.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an inherited heart muscle disease that predominantly affects the right ventricle. Clinical manifestations are related to severe ventricular arrhythmia that may lead to sudden death, mostly in young patients. Magnetic resonance imaging (MRI), included in the new diagnostic criteria since 2010, aims to detect segmental and global wall motion abnormalities, reduced ejection fraction, right ventricular dilatation and right ventricular diastolic/systolic dysfunction. An MRI assessment of the right ventricle is often challenging, partly because the MRI diagnostic criteria have some limitations, and also because it requires a significant learning curve due to the low prevalence of the disease. Therefore, this article aims to review the pathophysiology of the disease, the cardiac MRI protocol, images of the various stages of this affection as well as the differential diagnosis. Copyright © 2015 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.
    02/2015; 96(5). DOI:10.1016/j.diii.2014.07.009
  • [Show abstract] [Hide abstract]
    ABSTRACT: Cardiomyopathy is an intrinsic structural disorder of the myocardium that may result in ventricular dysfunction and can progress to clinical heart failure. Non-invasive imaging modalities can determine whether abnormalities are present in the myocardium, valves, pericardium, or vessels. These imaging techniques can also present important prognostic information, as well as direct treatment and further management. Echocardiography is the most common imaging technique used for the initial diagnosis and management of cardiomyopathy; however, other imaging modalities, including nuclear cardiac imaging, cardiac magnetic resonance imaging, and cardiac computed tomography, may play an important role depending on the underlying etiology of the cardiomyopathy. This article reviews the role of non-invasive imaging in the work-up and management of patients with cardiomyopathy.
    Current Atherosclerosis Reports 03/2015; 17(3):486. DOI:10.1007/s11883-014-0486-1 · 3.06 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cardiac magnetic resonance imaging (CMR) is often used in athletes to image cardiac anatomy and function and is increasingly requested in the context of screening for pathology that can cause sudden cardiac death (SCD). In this thesis, patterns of cardiac adaptation to sports are investigated with CMR. Chapter 2 describes our finding that left-right ratios are preserved across all sports categories, and that these ratios are similar to those found in non-athletic controls. The ratio of ventricular volume and wall mass is also similar across sports categories and non-athletic controls. Besides providing additional sports category-specific CMR reference values and upper limits for athletes, we also found that sports category is an important determinant of ventricular dimensions, irrespective of training hours, age and gender. Sports that involve dynamic (endurance) exercise are associated with larger volumes and wall mass, while the largest values are found in combined high dynamic-high static (strength-endurance) sports. Purely high static (strength) sports do not result in significant increases of ventricular volume and wall mass. Previous studies by others that reported selectively increased wall mass in strength-trained athletes may have been confounded by the concealed use of anabolic androgenic steroids (AAS) amongst their populations. A comparison of AAS-using strength athletes with non-AAS-using strength athletes in chapter 3 shows a significant association between AAS use and larger ventricular dimensions, in combination with impaired diastolic and systolic ventricular function. In chapter 4 we found that athletes of black ethnicity have significantly more pronounced ventricular hypertrabeculation, resembling left ventricular non-compaction (LVNC). Ethnicity proved to be an important determinant of hypertrabeculation, which in turn was associated with reduced ejection fraction. As the increased trabeculation is probably benign and physiological, it is important to be aware of this to prevent confusion of LVNC with increased hypertrabeculation as seen in black athletes. The relatively preserved volume-to-mass and left-to-right ratios are investigated further in chapter 5 and chapter 6, as a tool to differentiate physiological cardiac adaptation from hypertrophic cardiomyopathy (HCM) and arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D), respectively. In HCM a predominant increase in ventricular wall mass is observed and the volume-to-mass ratio is effective at differentiating between patients and controls. ARVC/D is associated with a disproportionately large right ventricle. The current diagnostic criteria make use of absolute RV cut-off values and could be improved upon by also considering the left-to-right ventricular volume ratio. This would help to prevent false positive findings, especially in athletes. In conclusion, this thesis adds to current basic knowledge on physiological cardiac changes in athletes and also provides possible differentiating parameters for clinical use.


Available from